Ori Biotech is a CGT manufacturing technology company.
Ori Biotech has raised €121M across 3 funding rounds from 7 investors, most recently a Series B round in Jan 2022. Based in London, UK; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2022-01-18 | Series B | €88M | Amadeus Capital Partners,Chimera Capital,Delin Ventures,Northpond Ventures,Novalis LifeSciences,Octopus Ventures+1 more | View deal → |
| 2020-10-15 | Series A | €26M | Northpond Ventures | View deal → |
| 2020-09-01 | Seed | €7.9M | — | View deal → |
